PureTech Health plc
PRTC.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | £1 | £1 | £1 | £1 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | £0 | £1 | £1 | £1 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | 475.3% | -64.1% | -79.1% | – |
| Gross Profit | £0 | -£0 | -£0 | -£0 |
| % Margin | 100% | -12,387.3% | -6,546.2% | -1,007% |
| EBITDA | £0 | -£0 | -£0 | -£0 |
| % Margin | 866.3% | -2,357.5% | -3,824.7% | -470.5% |
| Net Income | £0 | -£0 | -£0 | -£0 |
| % Margin | 1,240.1% | -8,759.6% | -2,409.3% | -606.9% |
| EPS Diluted | 0.2 | -0.24 | -0.18 | -0.21 |
| % Growth | 183.3% | -33.3% | 14.3% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |